CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE
|
|
- Sibyl Blankenship
- 6 years ago
- Views:
Transcription
1 F- 15 CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE Assembled by: Tim Maillet, OD, BSc NSAO Practice Innovations Committee Chairperson September 2009
2 F- 16 Ocular Allergies Acute Allergy Therapy: Brand Generic Manufacturer Bottle Size Dosing Acular LS Ketorolac Allergan 5ml, 10ml QID tromethamine 0.4% Alrex Loteprednol Bausch & 5ml, 10ml QID etabonate 0.2% Lomb Emadine Emedastine Alcon 5ml QID difumarate 0.05% Patanol Olopatadine Alcon 5ml BID Refresh Eye Antazoline Allergan 5ml BID Allergy Relief phosphate 0.51%, 0.051% Zaditor Ketotifen fumarate 0.025% Novartis 5ml BID Chronic Allergy Therapy: Brand Generic Manufacturer Bottle Size Dosing Alocril Nedocromil Allergan 5ml BID sodium 2% Alomide Iodoxamide Alcon 10ml QID tromethamine Opticrom Cromolyn sodium 4% Allergan 10ml QID Antimicrobial Agents Fluoroquinolones: Brand Generic Ciloxan, Ciprofloxacin and 0.3% Ocuflox, Ofloxacin and 0.3% Vigamox Moxifloxacin Zymar Gatifloxacin 0.3% Manufacturer Preparation Pediatric Bottle/Tube Alcon, and Sol/ung 1yr/ 2yr 2.5ml, 5ml, 10ml/3.5g Allergan, and Sol 1yr 5ml, 10ml Alcon Sol 1yr 3ml Allergan Sol 1yr 2.5ml, 5ml Aminoglycosides: Brand Generic Manufacturer Preparation Pediatric Bottle/Tube Tobrex, and Tobramycin Alcon, and Sol/ung 2mos. 5ml/3.5g
3 F % Polymyxin B Combinations: Brand Generic Polytrim Polymyxin B and trimethoprim Polysporin Polymyxin B and bacitracin Neosporin Polymyxin B, neomycin, and gramicidin Manufacturer Preparation Pediatric Bottle/Tube Allergan, and Sol 2mos. 10ml Monarch, and Monarch, and Ung N/A 3.5g Sol/ung N/A 10ml/3.5g Fusidic Acid: Brand Fucithalmic Generic 1% fusidic acid Manufacturer Preparation Pediatric Bottle/Tube Leo Pharma Viscous sol >2 years Unit dose Inc. 3 or 5g tube Erythromycin: Brand Erythromycin ophthalmic Generic Erythromycin Manufacturer Preparation Pediatric Bottle/Tube Bausch & Ointment Yes 3.5g Lomb Over-the-counter Anti-Infectives: Product Antibiotic Preservative Optimyxin Eye/Ear gramicidin 0.025mg/mL polymyxin B IU/mL Optimyxin Ointment bacitracin 500 IU/g polymyxin B IU/mL None Polysporin Eye/Ear Polysporin Ophthalmic Ointment gramicidin 0.025mg/mL polymyxin B IU/mL bacitracin 500 IU/g polymyxin B IU/mL None Herpes Infections: Brand Generic Manufacturer Preparation Bottle/Tube Viroptic Trifluridine 1% Monarch Pharm Solution 7.5ml Zovirax Acyclovir GlaxoSmithKline Capsules 200mg Valtrex Valacyclovir GlaxoSmithKline Caplets 500mg Famvir Famciclovir Novartis Tablets 500mg
4 F- 18 Anti-inflammatory Agents Corticosteroid/Antibiotic Combination Drugs: Brand Manufacturer Steroid Antibiotic Preparation Bottle/Tube Blephamide Allergan Prednisolone acetate 0.2% Sodium sulfacetamide Susp./ung. 2.5ml, 5ml, 10ml/3.5g Cortisporin Monarch Hydrocortisone 1% FML-S Allergan Fluorometholone Maxitrol Alcon Dexamethasone Tobradex Alcon Dexamethasone 10% Neomycin 0.35%, polymyxin B 10,000u/ml Sodium sulfacetamide 10% Neomycin 0.35%, polymyxin B 10,000u/ml Tobramycin 0.3% Suspension Suspension Susp./ung. Susp./ung. 7.5ml 5ml, 10ml 5ml/3.5g 2.5ml, 5ml/3.5g Maximum Strength Topical Corticosteroid Drugs: Brand Generic Manufacturer Preparation Bottle/Tube Lotemax Loteprednol etabonate Bausch & Lomb Suspension 2.5ml, 5ml, 10ml, 15ml Pred forte, and Prednisolone acetate 1% Allergan, and Suspension 1ml, 5ml, 10ml, 15ml Vexol Rimexolone 1% Alcon Suspension 5ml, 10ml Moderate Strength Topical Corticosteroid Drugs: Brand Generic Manufacturer Preparation Bottle/Tube Flarex, and Fluorometholone Alcon Suspension 5ml, 10ml acetate FML, and Fluorometholone alcohol Allergan Suspension 5ml, 10ml, 15ml Pred Mild, and Prednisolone acetate 0.12% Allergan Suspension 5ml, 10ml To Taper Steroids: An important reason for tapering steroids is the rebound effect of local inflammation. Abruptly discontinuing topical steroids may allow the suppressed inflammation to bounce back. A good rule of thumb: taper dosage frequency by about a 50% reduction once inflammation is under control. Example: Q1H for two days, Q2H for two days, QID for four days, BID for four days. Non-steroidal Anti-inflammatory Drugs: Brand Generic Manufacturer Preparation Bottle/Tube Voltaren diclofenac Novartis Solution 5ml sodium Ophthalmics Ocufen 0.03% Allergan Solution 2.5ml flurbiprofen sodium Acular ketorolac Allergan Solution 3ml, 5ml, 10ml tromethamine Acular LS 0.4% ketorolac tromethamine Allergan Solution 3ml, 5ml, 10ml
5 F- 19 Topical Glaucoma Drugs Beta Blockers: Brand Generic Manufacturer Concentration Bottle Size Betagan, and Levobunolol Allergan 0.25% 5ml, 10ml 2ml, 5ml, 10ml, 15ml Betoptic-S Betaxolol Alcon 0.25% 2.5ml, 5ml, Timoptic, and Timoptic-XE, and Timolol maleate Timolol maleate Merck, and Merck, and 10ml, 15ml 0.25%, Unit-dose, 2.5ml, 5ml, 10ml, 15ml 0.25%, 2.5ml, 5ml Prostaglandin Analogs: Brand Generic Manufacturer Concentration Bottle Size Lumigan Bimatoprost Allergan 0.03% 2.5ml, 5ml, 7.5ml Travatan Travoprost Alcon 0.004% 2.5ml, 5ml Travatan Z Travoprost Alcon 0.004% 2.5ml, 5ml Xalatan Latanoprost Pfizer 0.005% 2.5ml Alpha Agonists: Brand Generic Manufacturer Concentration Bottle Size Alphagan P, and Brimonidine Allergan,, 0.15%, 0.2% 5ml, 10ml, 15ml Iopidine Apraclonidine Alcon 1% 5ml, 10ml unit-dose Carbonic Anhydrase Inhibitors: Brand Generic Manufacturer Concentration Bottle Size Azopt Brinzolamide Alcon 1% 5ml, 10ml, 15ml Trusopt Dorzolamide Merck 2% 5ml, 10ml Combination Glaucoma Medications: Brand Generic Manufacturer Concentration Bottle Size Combigan Brimonidine/timolol Allergan 2%/ 5ml, 10ml Cosopt Dorzolamide/timolol Merck 2%/ 5ml, 10ml Miscellaneous Hyperosmolar Agents: Brand Generic Muro 128 5% sodium 5% chloride Muro 128 5% sodium 5% chloride Manufacturer Preparation Bottle/Tube Dosing Bausch & Lomb Bausch & Lomb Solution 15ml, 30ml 1gt/2gtt Q3-4H Ointment 3.5g Q3-4H
6 F- 20 Mydriatics and Cycloplegics: Generic Trade Concentration Onset Duration of Action Phenylephrine AK-Dilate Sol, 2.5%, 10% min 3-5 h Mydfrin Sol, 2.5% Atropine sulfate Isopto Atropine Sol, 1% min 7-14 days Cyclopentolate AK-Pentolate Sol, 1% min 6-24 h Cyclogyl Cylate Sol,, 1%, 2% Homatropine Isopto Sol, 2%, 5% min 3 days hydrobromide Homatropine Tropicamide Mydriacyl Sol,, 1% min 4-6 h Topical Anesthetic Agents: USP or NF Trade Concentration Proparacaine Alcaine Ophthetic Dry Eye Therapy Temporary Preservative: Product Preservative Lubricant Refresh Tears Purite CMC Refresh Contacts Purite CMC Refresh Ultra Purite Castor oil + glycerin 1% + polysorbate 80 GenTeal Sodium perborate HPMC 0.3% GenTeal Gel Sodium perborate HPMC + CMC Blink Purite Sodium hyaluronate Chemical Preservative: Product Preservative Lubricant Tears Naturale II Polyquad Duasorb: Dextran + HPMC 0.3% Tears Naturale Forte Polyquad Trisorb: Dextran + HPMC 0.3% + Glycerin Tears Naturale + EDTA Duasorb: Dextran + HPMC 0.3% Eyestil multidose Sodium Hyaluronate Hypotears + EDTA PEG PVA 1% Murine + EDTA PVA Visine PEG + Glycerin + HPMC 0.2% Systane Polyquad PEG + Propylene Glycol + HP Guar Systane Ultra Polyquad PEG + Propylene Glycol + HP Guar Isopto Tears HPMC Isopto Tears 1% HPMC 1% Blink n Clean PHMB Tears Plus Chlorbutanol PVA + Povidone Moisture Eyes Propylene Glycol 1% + Glycerin 0.3%
7 F- 21 Preservative-Free: Product Preservative Lubricant Artelac None Hypromellose USP 0.32% Refresh Plus None CMC Thera Tears None CMC 0.25% Tears Natural Free None Duasorb Bion Tears None Duasorb Eyestil unidose None Sodium Hyaluronate Tears Plus None PVA + PEG Gels with Temporary Preservative: Product Preservative Lubricant Refresh Liquigel Purite CMC 1% GenTeal Gel Sodium perborate HPMC 0.3% Gels with Chemical Preservative: Product Preservative Lubricant Tear Gel Cetremide Carbomer 980 Liposic Cetremide Carbomer 980 Preservative-Free Gels: Product Preservative Lubricant Celluvisc None CMC 1% Preservative-Free Emulsion: Product Preservative Lubricant Refresh Endura None Castor Oil + Polysorbate 80 + Glycerin + Carbomer 1342 Preservative-Free Ointments: Product Preservative Lubricants Hypotears Ointment None White petrolatum + mineral oil Duolube None White petrolatum + mineral oil Lacrilube None White petrolatum + mineral oil Tears Natural PM None White petrolatum + mineral oil + Lanolin
8 F- 22 Ocular Decongestants Product Decongestant Antihistamine Other Preservative Albalon PVA + EDTA Albalon-A antazoline PVA + EDTA phosphate B&L Allergy PEG 0.012% Cromolyn Eye Clear Eyes 0.012% Naphcon-A 0.025% Naphcon Forte Opcon-A 0.025% Opticrom Vasocon Vasocon-A Visine Allergy Eye Visine Cool eye Visine Original Eye Visine Workplace Eye 0.05% 0.05% tetrahydrozoline 0.05% tetrahydrozoline 0.05% tetrahydrozoline 0.025% oxymetazoline 0.3% pheniramine maleate 0.3% pheniramine maleate antazoline phosphate 2% sodium cromoglycate HPMC 2% sodium cromoglycate 0.25% zinc sulfate 1% polyethylene glycol
Drugs That May Be Used by Certain Optometrists
Drugs That May Be Used by Certain Optometrists Approved drugs. (a) Administration and prescription of pharmaceutical agents. Optometrists who are certified to prescribe and administer pharmaceutical agents
More information11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and
11 Eye To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and The Royal College of Ophthalmologists guidelines Index 11.1 Administration
More informationTHE PEDIATRIC RED EYE (Handout)
THE PEDIATRIC RED EYE (Handout) Ida Chung, OD, MSHE, FCOVD, FAAO Western University College of Optometry Associate Professor/Assistant Dean of Learning 309 E. Second Street, Pomona, CA 91766 Office: 909-938-4140
More informationMiotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.
Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation
More information4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.
Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation Increase
More informationOPHTHALMIC MEDICATIONS
OPHTHALMIC MEDICATIONS Ally Cuddy, PharmD PGY1 Pharmacy Resident September 7, 2017 AMERICAN ACADEMY OF OPHTHALMOLOGY American Academy of Ophthalmology. 2015. CASE #1 TR is a 76 YOM with no significant
More informationBNF CHAPTER 11: EYE 1 January 2018
BNF CHAPTER 11: EYE 1 BNF 11.3.1 ANTIBACTERIALS First Choice. Broad spectrum. Chloramphenicol 0.5% Eye Drops Administration Alternative Administration Eye drops, apply 1 drop at least every 2 hours then
More informationOcular Medication and Compliance
Ocular Medication and Compliance Consultant for Alcon Disclosures CECELIA KOETTING, OD FAAO VIRGINIA EYE CONSULTANTS VOA CONFERENCE NORFOLK 2018 Virginia Optometry License Generic vs Brand Name Every state
More informationDeveloped by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology
Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing
More informationOphthalmic Medication Review and Update. Scott Ensor, OD, MS Associate Professor Southern College of Optometry
Ophthalmic Medication Review and Update Scott Ensor, OD, MS Associate Professor Southern College of Optometry Financial Disclosures None! About Me Native Memphian 2001 SCO Graduate Primary Care Residency
More information11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products
1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic
More informationCompleted Clinical Research Trials Monte Dirks, M.D.
Completed Clinical Research Trials Monte Dirks, M.D. Monte Dirks, M.D. - Primary Investigator Norfloxacin -Merck (1986) Safety and efficacy of norfloxacin vs. tobramycin in the treatment of external ocular
More informationMEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Eye & Ear Anti-Inflammatory Disorders P & T DATE 9/12/2017 THERAPEUTIC CLASS Topical Anti-Inflammatory Agents REVIEW HISTORY
More informationHigh on Drugs. Erythromycin Only in ointment
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 High on Drugs Joseph Shetler, O.D. 112 North Main Gordon, NE shetlerg@gpcom.net Part I : Drugs commonly used in optometric practices Antibiotics Fluorquinolones Highly
More informationFinancial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy
The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy Danica J. Marrelli, OD, FAAO University of Houston College of Optometry Financial Disclosure I have received I have received speaking
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 28 May 2008 COSOPT 20 mg/5 mg/ml, eye drops, solution in single dose container Box of 60 0.2 ml single dose containers
More information11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products
1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic
More informationOphthalmic Special Order Products, General Principles
Ophthalmic Special Order Products, General Principles When clinically appropriate and available, licensed products should always be prescribed and dispensed in preference to unlicensed products. Certain
More information79 C. Michael Davenport Blvd. Suite A Frankfort, KY August 5, Dear Kentucky Medicaid Provider:
79 C. Michael Davenport Blvd. Suite A Frankfort, KY 40601 August 5, 2010 Dear Kentucky Medicaid Provider: Please be advised that the Department for Medicaid Services is making changes to the Kentucky Medicaid
More informationPATIENT CASE HISTORY. General Health Medications Allergies
OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in
More informationPremera Blue Cross Medicare Advantage Plans Pharmacy Policy Updates
Premera Blue Cross Medicare Advantage Plans Pharmacy Policy Updates Most Part D-eligible drugs and drug policies are not effective and administered until Centers for Medicare and Medicaid Services approval
More informationOphthalmic Special Order Products, General Principles
Ophthalmic Special Order Products, General Principles When clinically appropriate and available, licensed products should always be prescribed and dispensed in preference to unlicensed products. Where
More informationCurrent Protocols Topical and Oral Medications for Ocular Disease
Current Protocols Topical and Oral Medications for Ocular Disease Jill Autry, RPh, OD Eye Center of Texas Ophthalmology Houston, TX DISCLOSURES Jill Autry, OD, RPh Tropical CE Continuing Education Company
More informationSouth East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway
Proceed to 2 nd line treatment if further reduction in IOP required and there is good response to PGAs or (& no South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension
More informationData from the recent therapeutic
Getting started in therapeutics Part 8a What drugs will I prescribe and supply? Continuing our series on therapeutics in practice, Lucy Titcomb and Professor John Lawrenson review the range of ophthalmic
More informationDQSA Listening Session June 6, 2017
DQSA Listening Session June 6, 2017 I am Allison Madson, manager of regulatory affairs, for the American Society of Cataract and Refractive Surgery. ASCRS is a medical specialty society representing nearly
More informationPrescribing Trends of Optometrists
Prescribing Trends of Optometrists A newly published article on optometric prescribing is exciting and highly reassuring. The optometric profession prescribed over four million medical prescriptions in
More informationManaging the Patient with POAG
Managing the Patient with POAG Vision Institute Annual Fall Conference Mitchell W. Dul, OD, MS, FAAO mdul@sunyopt.edu Richard J. Madonna, MA, OD, FAAO rmadonna@sunyopt.edu Ocular Hypertension (OHT) Most
More informationVolume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT)
Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire
More informationACETAZOLAMIDE (a-seet-a-zole-a-mide)
EYES Medicines for glaucoma Other medicines for glaucoma Active ingredients (generic names) ACETAZOLAMIDE (a-seet-a-zole-a-mide) Common brands include: Diamox, Glaumox What it is used for Acute glaucoma
More informationDry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.
Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole
More informationFee-For-Service Pharmacy Provider Notice #182 March 2014 P&T Changes
Fee-For-Service Pharmacy Provider Notice #182 March 2014 P&T Changes July 7, 2014 11013 W. Broad Street Glen Allen, VA 23060 Dear Kentucky Medicaid Provider: Please be advised that the Department for Medicaid
More informationSpeakers. Learning Objectives. Major Contributor. HPI Approach to the Patient with Red Eye. 1. Unilateral or bilateral?
Speakers John West, M.D. Katie West, 4 th year Optometry Student John West, M.S., M.D. McCook Clinic, P.C. McCook, Nebraska University of Nebraska Medical Center (Omaha, NE) Volunteer Faculty-Family Medicine
More informationTreatments for Open-Angle Glaucoma. A Review of the Research for Adults
Treatments for Open-Angle Glaucoma A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your eye doctor has said that you have open-angle glaucoma,
More informationP R O D U C T L I S T S E P T E M B E R
PRODUCT LIST SEPTEMBER 2017 Alprazolam Tablets, USP CIV (brand-name Xanax ) 59762-3719-1 0.25 mg tablets 100 tablets/bottle 48 59762-3719-3 0.25 mg tablets 500 tablets/bottle 48 59762-3719-4 0.25 mg tablets
More informationWellCare of South Carolina Preferred Drug List Update
WellCare of South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on August 21,
More informationThe State of Therapeutics in Eye Care (Part II)
The State of Therapeutics in Eye Care (Part II) Ron Melton, OD, FAAO Randall Thomas, OD, MPH, FAAO The comprehensive ophthalmologist should be comfortable in using and prescribing the treatments for stages
More informationOutline. Financial Disclosures. Outline. Importance. Importance 2/13/2014
Brad Genereux, OD February 8 th, 2014 Anti-infective (bacterial, viral, fungal) Financial Disclosures No disclosures Importance Know drugs you re administering to patient Patient education Reactions Triage
More informationPharma X Consultancy Inc. Inventory List
Pharma X Consultancy Inc. Inventory List Location: Pharma X Consultancy Inc 2 Aceclofenac 100mg Tablets 60S 1205 ID Aciclovir 200mg Tablets 25S 1213 Aciclovir 400mg Tablets 56S 1214 Aciclovir 5% Cream
More informationPGAs. Glaucoma Pharmacology A-Z. Selecting Therapy. PGAs Prostaglandin analogs. Prostaglandin Side Effects 1/6/2014
PGAs Glaucoma Pharmacology A-Z Eric E. Schmidt, O.D. Omni Eye Specialists Wilmington, NC schmidtyvision@msn.com QHS dosing Long duration of action Flatten diurnal curve Effective on trough and peak IOP
More informationEye Disorders in Primary Care
Friday General Session Eye Disorders in Primary Care Robert D. Gross, MD Pediatric Ophthalmologist, Private Practice Children s Eye Specialists, PA Dallas, Texas Educational Objectives By the end of this
More information11 Eye. regarding this product in this setting. As a result we cannot recommend its use within NHSScotland.
Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered
More information12/3/2011. Disclosure. Allergic Eye Disease: Diagnostic Pearls and Treatment Options. Symptoms. Allergy Eye Disease
Disclosure Allergic Eye Disease: Diagnostic Pearls and Treatment Options I have no financial relationships to disclose. Ophthalmology Update 2011 Matilda Chan MD, PhD Department of Ophthalmology, UCSF
More informationREFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS*
APPENDIX III REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS* *Excluding preparations for use in the treatment of dry eye 1 Antazoline Sulphate (P) For the temporary relief
More informationTreatment of Uncontrolled Anterior Uveitis with 5- Fluorouracil: Case Series
CASE STUDIES Treatment of Uncontrolled Anterior Uveitis with 5- Fluorouracil: Case Series Osama Mohammed Badeeb MD, FRCS(C), Ahmad Mohammed Bawazeer MD, FRCS(C) Department Of Ophthalmology, King Abdulaziz
More informationVision Health: Conditions, Disorders & Treatments GLAUCOMA
Vision Health: Conditions, Disorders & Treatments GLAUCOMA Glaucoma is a disease of the optic nerve, which transmits the images you see from the eye to the brain. The optic nerve is made up of many nerve
More informationMODULE 10:12 COURSE CODE: C-5848
30 MODULE 10:12 COURSE CODE: C-5848 Drugs used in the treatment of dry eye syndrome, anti-inflammatory drugs and topical anti-allergy drugs Elaine Mann This article will cover the factors causing dry eye
More informationDapiprazole Hydrochloride 0.5% Erythromycin. Antibacterial Medications. Comprehensive Pharmacology Update
Comprehensive Pharmacology Update Ron Melton, OD, FAAO Randall Thomas, OD, MPH, FAAO www.eyeupdate.com 2009: A TPA Odyssey Are We There Yet? Vision Institute of Canada Annual Fall Conference and Trade
More informationP R O D U C T L I S T N O V E M B E R
PRODUCT LIST NOVEMBER 2018 Alprazolam Tablets, USP CIV (brand-name Xanax ) 59762-3719-1 0.25 mg tablets 100 tablets/bottle 48 59762-3719-3 0.25 mg tablets 500 tablets/bottle 48 59762-3719-4 0.25 mg tablets
More informationA Compendium of Product information & Indicative manufacturer s prices
A Compendium of Product information & Indicative manufacturer s prices (March 2012) for 28-days treatment with commonly used -free eye drops & ointments This information has been produced for prescribing
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)
Guidelines for the medical treatment of chronic open angle glaucoma and ocular hypertension Summary: DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Diagnosis and management of ocular hypertension (OHT)
More informationROBERT L. SHIELDS, M.D. GLAUCOMA SURGERY AND TREATMENT
1 CURRICULUM VITAE ROBERT L. SHIELDS, M.D. GLAUCOMA SURGERY AND TREATMENT University of Colorado Health Eye Center Cherry Creek 2000 South Colorado Boulevard Annex Building, Suite 100 Denver, Colorado
More informationHerpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry
Herpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry I have what?! How to break the news Meet the Herpes Quick virology
More informationFinancial Disclosures. Pharmacology Rounds. #1) Topical Antibiotics Fourth Generation Fluoroquinolones. Fourth generations 2/20/2018
Financial Disclosures Nothing to disclose Pharmacology Rounds Brad Sutton, OD, FAAO Clinical Professor IU School of Optometry brsutton@indiana.edu #1) Topical Antibiotics Fourth Generation Fluoroquinolones
More informationLong Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5
RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 PREAMBLE Significance: Glaucoma occurs in 1-2% of white people aged over 40 years, rising to 5% at 70 years and exponentially with advancing
More informationBrightFocus Foundation is the new name for American Health Assistance Foundation.
In this section, you will find the following: Glaucoma Medications Laser Therapies Conventional Surgical Procedures In the second section, you will find information on how to search for potential treatments
More information10/12/2018. Pharmacology Rounds. Brad Sutton, OD, FAAO Clinical Professor IU School of Opt. Fourth Generation Fluoroquinolones #1) Topical Antibiotics
Pharmacology Rounds Brad Sutton, OD, FAAO Clinical Professor IU School of Opt. Please silence all mobile devices and remove items from chairs so others can sit. Unauthorized recording of this session is
More information11 Eye. systemic disease or both eyes are affected (or 1 eye is affected if the second eye has poor visual acuity) and
Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered
More informationOPR OPTOMETRIC PRACTICE REFERENCE STANDARDS OF PRACTICE
OPR OPTOMETRIC PRACTICE REFERENCE The best eye health and vision for everyone in Ontario, through excellence in optometric care. Publishing History The Guide to the Clinical Practice of Optometry FIRST
More informationCourse Outline PHARMACOLOGY FOR TECHS. Pharmacokinetics. Eyedrops. Punctal occlusion. Eye drop administration 4/6/2016
Course Outline Examine common ophthalmic medications - topical and systemic, diagnostic, therapeutic Indications/usage Dosage and means of administration Side effects Examine systemic medications and their
More informationThis application applies to the following medicines for ophthalmic use:
10 January 2007 Medicines Classification Committee MedSafe Ministry of Health PO Box 5013 WELLINGTON RE: SUBMISSION FOR RE-CLASSIFICATION OF PHARMACY-ONLY EYE PREPARATIONS TO ALLOW SUPPLY BY OPTOMETRIST
More informationWhat is Pet Poison Helpline?
Clear Eyes, Dry Nose, No Problem? Wrong! Intoxications due to Eye Drops and Nasal Sprays November 14, 2017 Colleen Almgren, DVM, PhD, DABT, DABVT Senior Veterinary Toxicologist Pet Poison Helpline calmgren@petpoisonhelpline.com
More informationOPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D.
OPHTHALMIC GENERIC FORMULATIONS BY ADREA R. BENKOFF, M.D. WHAT YOU NEED TO KNOW ABOUT OPHTHALMIC GENERICS GENERIC REQUIREMENTS WHO MAKES GENERIC OPHTHALMIC PRODUCTS DO THEY WORK AS WELL AS THE BRAND PRODUCT
More informationCommon Eye Problems. Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc.
Common Eye Problems for Subspecialists 2018 Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc. I have no financial disclosures to make. Goals of Course Evaluation and management of the red
More informationCurrent Trends in Medical Management
Current Trends in Medical Management Ron Melton, OD, FAAO Randall Thomas, OD, FAAO www.eyeupdate.com Financial Disclosure Dr. Ron Melton and Dr. Randall Thomas are consultants to, on the speakers bureau
More informationEssential Topical Formulary. Carlo J. Pelino, OD, FAAO Joseph J. Pizzimenti, OD, FAAO.
Essential Topical Formulary Carlo J. Pelino, OD, FAAO Joseph J. Pizzimenti, OD, FAAO pizzisfl@gmail.com Course Description The ability to use pharmaceutical agents has enabled optometrists to become true
More informationOHTS Baseline/Randomization Visit: BR
Page 1 of 5 2/28/5 OHBR02.00 Coordinating Center use only Rec d... Log d... Chk d... Entr d... Checklist Check when completed Before exam, patient first completes SF-36 Quality of Life Before exam, patient
More information30. Beta Adrenergic Receptor Blocking Agents Acebutolol Carteolol (Cartrol) February 12, 2003 Penbutolol (Levatol) Propranolol (Inderal LA)
#03-01 Prior Authorization PDL Implementation Schedule UPDATES Drugs on PDL Drugs which Require PA Implementation Date 26. Bone Resorption Suppression Agents Alendronate (Fosamax) Etidronate (Didronel)
More informationEducators in Primary Eyecare Lecture Series by Drs. Ron Melton and Randall Thomas
Educators in Primary Eyecare Lecture Series by Drs. Ron Melton and Randall Thomas Past recipients of the Glaucoma Educator of the Year Award by the American Academy of Optometry Authors of Review of Optometry
More informationCurrent Therapy in Ocular Disease
Current Therapy in Ocular Disease by Drs. Ron Melton and Randall Thomas Past recipients of the Glaucoma Educator of the Year Award by the American Academy of Optometry Authors of Review of Optometry s
More informationLearn Connect Succeed. JCAHPO Regional Meetings 2017
Learn Connect Succeed JCAHPO Regional Meetings 2017 Financial Disclosure Advanced Ophthalmic Pharmacology: A Practical Approach I have no financial interests in this presentation Trade and generic names
More informationMAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.
PRESCRIBING INFORMATION Pr MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.1% w/w Pr MAXITROL* Neomycin and Polymyxin B
More informationReason for Unscheduled Visit
Page 1 of 7 OHUN16.01 MULE: UNREASONS Reason for Unscheduled Visit * On any given page, any section started should be completed. Check all that apply: 1. Confirmation of IOP... Complete Snellen, IOP, Ocular
More informationEye Disorders in Primary Care
Texas Academy of Family Physicians San Antonio, TX June 8, 2018 Eye Disorders in Primary Care Robert D. Gross, MD, FACS Clinical Professor of Ophthalmology UT Southwestern Medical Center Dallas, Texas
More informationAbbreviated Update: Ophthalmic Glaucoma Agents
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Abbreviated Update: Ophthalmic Glaucoma Agents Month/Year
More informationVisit Type (Check one)
Page 1 of 14 OHFV21.01 MULE: Page 1 Visit Type (Check one) Visit prior to 078 month visit enter visit window 0 Semi-Annual: Annual: 078 mo. 090 mo. 102 mo. 114 mo. 126 mo. 138 mo. 150 mo. 162 mo. 084 mo.
More informationSecretary for Health and Family Services Selections for Preferred Products
Secretary for Health and Family Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Secretary for Health and Family Services based
More informationUpdate on Glaucoma Medical Therapy
Update on Glaucoma Medical Therapy Murray Fingeret, OD Disclosures Consultant Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Dyopsys, Heidelberg Engineering, Reichert, Topcon Glaucoma Therapy An Overview
More informationConjunctivitis - Allergic, Seasonal & Perennial (1 of 6) Patient presents w/ symptoms suggestive of allergic conjunctivitis
, Seasonal & Perennial ( of 6) A B Patient presents w/ symptoms suggestive of allergic conjunctivitis Non-pharmacological therapy 2 DIAGNOSIS Does the clinical presentation confirm seasonal or perennial
More informationSteroids and Controlled Substances
Steroids and Controlled Substances Marc R. Bloomenstein OD, FAAO Scottsdale, Arizona Disclosure Presenter is on speakers panel of Alcon, Allergan, Abbott, Bausch + Lomb, Inspire, STAAR Surgical, Odyssey
More informationAgenda. What s Up with OSD? 5/14/2015. OSD presents a significant challenge to physicians NEW CONCEPTS IN OCULAR SURFACE DISEASE
NEW CONCEPTS IN OCULAR SURFACE DISEASE Blair B Lonsberry, MS, OD, MEd., FAAO Diplomate, American Board of Optometry Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu
More informationPage 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis
The RED EYE and ALLERGIC EYE DISEASE DIAGNOSIS & MANAGEMENT Frank Larkin Moorfields Eye Hospital RED EYES conjunctivitis keratitis episcleritis / scleritis acute glaucoma anterior uveitis post-op. / trauma
More informationPediatric use of topical ophthalmic drugs
Pediatric use of topical ophthalmic drugs Rachel Anastasia Coulter, O.D. Nova Southeastern University. College of Optometry, Ft Lauderdale, Florida Background: Changes in the policies of the Food and Drug
More informationPediatric Potpourri. Pediatric Headaches When Should I Worry? Financial Disclosures 5/12/2015. Headache History. Headache History
Pediatric Potpourri Susan Cotter, OD, MS, FAAO Marshall B Ketchum University scotter@ketchum.edu Financial Disclosures Commercial: none (SAC, EJ) Salary support: NIH/NEI (SAC, EJ) Erin Jenewein, OD, MS,
More informationINDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.
Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) ACULAR 0,4% COMPOSITION ACULAR 0,4% ophthalmic solution contains: Ketorolac tromethamine: 4 mg/ml Preservative: Benzalkonium chloride
More informationDry Eye Prescribing Guidelines
Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on
More informationEast and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults
East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults Introduction Glaucoma is a group of eye diseases causing optic nerve damage. In most cases
More informationChallenging Anterior Segment Cases. Benjamin P. Casella, OD, FAAO
Challenging Anterior Segment Cases Benjamin P. Casella, OD, FAAO Bpc81@aol.com Disclosures Have lectured or been a consultant for: Allergan Carl Zeiss Hydrogel Vision 31yoWM My eye is irritated, and I
More informationPATIENT CASE HISTORY. General Health Medications Allergies
OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA, OSC ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist
More informationGLAUCOMA (2006) PHILIPPINE GLAUCOMA SOCIETY
GLAUCOMA (2006) PHILIPPINE GLAUCOMA SOCIETY CPM 9 TH EDITION Philippine Glaucoma Society (PGS) Correspondence to: Eye Referral Center, T. M. Kalaw Street, Ermita, Manila Telephone: 524-7119/525-9360 Mobile:
More informationPacking List SS#: From: HEALTH PARTNERS INTERNATIONAL 2907 PORTLAND DRIVE OAKVILLE ON CANADA L6H 5S4. Ship to: Carrier:
30 907 PORTLAND DRIVE OAKVILLE ON CANADA LH S4 PHONE:(90) 70-990 X FAX:(90) 70-74 ShipDate: /9/ Shipper# PTP30- Bott/0ml 0 TUBE/7G Tube/30g Box/ Box/ Kaopectate OS 70mg/mL, Bottle/0mL 790043 Attapulgite
More informationOphthalmology in Primary Care. Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc.
Ophthalmology in Primary Care Claudia U. Richter, M.D. Ophthalmic Consultants of Boston, Inc. No financial disclosures Objectives Red eye Nonvision threatening Vision threatening Cataracts Red Flag Signs
More informationOCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level.
OCULAR PHARMACOLOGY GLAUCOMA increased intraocular pressure normally 12 20 mm Hg. when to Tx no fixed level. literature sets ~21 mm Hg as upper limit of normal. some safe at 30 mm Hg some may have damage
More informationClass Update: Ophthalmic Glaucoma Agents
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Class Update: Ophthalmic Glaucoma Agents Month/Year
More informationClass Update with New Drug Evaluation: Glaucoma Drugs
Class Update with New Drug Evaluation: Glaucoma Drugs Date of Review: May 2018 Date of Last Review: January 2015 End Date of Literature Search: 02/26/2018 Generic Name: latanoprostene bunod Brand Name
More informationOphthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management Branch
May 2017 Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers Executive Summary Page 1 of 5 Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management
More informationGlaucoma Pharmacology A-Z
GLAUCOMA PHARMACOLOGY A-Z ERIC E. SCHMIDT, O.D., F.A.A.O. Building-block approach to medical therapy Establish the strongest foundation prior to resorting to adjunctive therapy OMNI EYE SPECIALISTS WILMINGTON,
More informationDifferential Diagnosis of Conjunctivitis and Keratoconjunctivitis
Differential Diagnosis of Conjunctivitis and Keratoconjunctivitis Dr. Victor Malinovsky 2006 Mechanical-Physical Trauma Corneal Abrasions Abrasions (interpalpebral/variable): a focal loss of epithelium
More informationStore between 39 F to 77 F (4 C to 25 C). Not to be taken internally. Keep out of reach of children.
CLIA Complexity: WAIVED For in vitro diagnostic use, Rx only. A CLIA Certificate of Waiver is required to perform the test in a waived setting. To obtain a Certificate of Waiver, please contact your state
More informationEmpowering Pharmacists to Improve Glaucoma Outcomes and Ocular Health
Ophthalmology in Focus Empowering Pharmacists to Improve Glaucoma Outcomes and Ocular Health Presenters Randall Seifert, PharmD Senior Associate Dean Professor Pharmacy Practice and Pharmaceutical Sciences
More information